Ariane Tom
InvestorDr. at Kaleida Capital
About
Dr. Ariane Tom leads Kaleida Capital, drawing on neurotech domain expertise to identify and back promising neurotechnology founders.
Invests in
AI & Machine LearningBiotechDeep TechMedical DevicesNew Materials
Deals · 4
SynchronLed round
via Kaleida Capital · filed May 2021
Anthropic AI Safety and ResearchLed round
via Kaleida Capital
OpenAILed round
via Kaleida Capital
AurenarLed round
via Kaleida Capital
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Kaleida Capital
Dr. Ariane Tom
Investor at Kaleida Capital
Edward Wood
Scientific Advisory Council at Kaleida Capital
Evan Schnell
Venture Partner at Kaleida Capital
Justin Trotter
Scientific Advisory Council at Kaleida Capital
Kevin Carlberg
Venture Partner at Kaleida Capital
Matt Angle
Scientific Advisory Council at Kaleida Capital
Max Hodak
Scientific Advisory Council at Kaleida Capital
Philip Sabes
Scientific Advisory Council at Kaleida Capital